Use of notes proceeds
Company: Core Scientific
The claim, verbatim
Core Scientific intends to use net proceeds for general corporate purposes, including working capital, operating expenses, capital expenditures, acquisitions of complementary businesses, or repurchases of its securities.
Source (primary)
core-scientific 8-K exhibit (exhibit991launchpressrelea.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-10-24)Live source ↗
Quote: “Core Scientific intends to use the net proceeds from the offering for general corporate purposes, including working capital, operating expenses, capital expenditures, acquisitions of complementary businesses, or repurchases of its securities”
How we checked this
This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.
Additional evidence
confirms core-scientific 8-K exhibit (exhibit991launchpressrelea.htm)
Quote: “Core Scientific intends to use the net proceeds from the offering for general corporate purposes, including working capital, operating expenses, capital expenditures, acquisitions of complementary businesses, or repurchases of its securities”